0IV3 trade ideas
"Holy Grail" buy on the weekly (Linda Rashke pattern)Market retreats to 20 period EMA after making new highs (for long positions)/lows (for shorts) with ADX (14period) >30. Some people use the 20 period SMA. Projection is a retest of the highs. Trailing stop. Failed grails tend to move (painfully) in the opposite direction.
$GERN Looking at uptrend.After the last few days of consolidation we find that GERN has broken its down trend with slight confirmation at a new uptrend. With that in mind the beginning of may should hold some value as data starts to surface and a shareholders meeting is set to take place around the 15th of May.
This is a long-term play with a lot of upside potential. Looking for a strong breakout. First target price is 5.25 followed by 5.80. This is conservative and I ask that everyone continue to remember that short volume is high, if margins need to cover this thing could break out strong to the upside. Continue to watch for developments.
Proud to see it holding solid above 4.00$ as of the time of this post. Looking for breakout above moving average to find new support, however, we seem to find solid support at the 4.00$ price point (for now.)
Hold.
wedge breakout followed by a new closing highIts looking like GERN could have a significant move tomorrow. Im looking for a strong move right out of the opening for a day trade.
$GERN, Geron Corp. may be making another nice advance upward.My opinion of this one is positive at this time. It appears it may be ready to make the final leg of a fairly major recovery to point B @ about $5.57. After witch it may make a significant long drop (wave C) to about the level of the peak of wave 1 about $2.62. That wave C, if it materializes should have a couple of really nice temporary bumps in it as it descends.
If you have other ideas, please post.
GERNI hadn't published this March 27th, 2018 (Evening). Was having some difficulties with internet-provider.
This was my current evaluation of GERN.
This is of course, a personal analysis and not much in-depth because of current workload at work.
Anyways, as I had saw it dropping towards 200EMA and if it had dropped (which it did), would have been an easy 5-10% gain. I didn't expect the 22% drop which was a surprise.
The overall trend is going to be a negative one, because it's completely losing momentum.
The company has released documentation within the Needham Healthcare Conference (not sure If I'm allowed links but I'll supply one from SeekingAlpha in case anyone would like to review (for themselves) seekingalpha.com
RSI is hitting rock bottom so expect a 3-5% rebound towards the UPSIDE as they'd call "Dead-Cat-Bounce". Then continuation towards DOWNSIDE.
As where I think this is heading, a possibly $3.70 but if we're in for a treat a juicy $2.70 :) (1-2mo projection)
Just my thoughts, take with a grain of salt and always be tight on risk-management.
GERNWatching for continued GERN breakout here. Weekly chart looks good with converging MACD lines. Looks to have bounced off a support level around $1.80.
Will watch for trend confirmation at $2.10 with a stop loss of $2.00 and price target of $2.80.
Daily chart:
The risk is worth the big upwards potentialDid some fundamental DD and i see many upside potential in this stock over the long term. Why is this stock so cheap to begin with? The stock is undervalued and should be at 8-10 dollar range atm.
Now is a good time to buy. Every negative thing that can happen is already baked in the stock price. Not much to short anymore. When things don't work out, i don't see the stock go completely to 0. Geron doesn't have any debts. Biotech is however risky, don't put all your life savings into this company...
Best case scenario this stock can soar to triple digits with a lot of volatility. First target is 20 dollar.
For now, let's wait for the catalist we need. FDA approval will take probably a year at least. Best case scenario few months before the end of this year. This far the clinical results of imetelstat look promising.
GERN potential break outPlaying safe: buy stop order just above consolidation range. Break out catalyst: earnings report. Target as shown.
GERN long ideasGERN looks ready to rebound off its recent low of 2.65, stoc went it's 30 and a bullish continuation seems to be forming
Volume on downtrend as well as current reversal is low however and should be preceded with exercised caution
$GERN Hang in there!Updating previous idea post. $GERN has not strayed from our troughs and did not fall through the $3.05 support . Created a projection line in black for possible expectations to break-even @ $3.23, possibly going positive to $3.30
News is neutral to negative with a reported earnings of $-0.05 per share, however the company has $146.7m in cash with positive outlook with Janssen Biotech.
Earnings Estimates Under Review.
To Bail Now Or Go Long?Entered @ $3.23 as a LONG position. Past week has been rough and tumultuous. It appears we are developing a short term wedge pattern in a long term uptrend. Up trending wedge patterns are usually results in a bearish breakdown. Stop loss set @ $3.00
@Andiki suggested Stop Loss at $2.94
Holding until Thursday and we will see what happens.
The U.S. (FDA) gave Geron Corp. some good newsGeron is surging today with positive regulatory news on a key drug candidate, and one trader apparently believes that those gains will hold.
1. finance.yahoo.com
2. stockcharts.com
3. 247wallst.com
Disclosure: I own GERON
Looking for vol. for confirmation of strong move to the upsideGeron was kneecapped by the FDA hold 4 months ago. The Mayo Clinic had a partial hold also levied on their research. Recently the FDA released the partial hold on the Mayo, and it is assumed GERN will use the same data to sway the FDA into releasing their hold. Also there will be a 1 for 24 share divi for GERN HOLDERS of record of May 28th in a new company Asterias --AST. This will take place before the end of July and should add some notice by the investment community. Mayo Clinic has been VERY bullish on Geron's Imetelstat drug for treating blood cancers and expect to see more data on their trials in the not too distant future. I think the squeezed BBs with bullish indications from both the Stochastics and MACD are indicating a high probability of a short term to intermediate term upwards move.
Geron CORP has upside potentialGeron CORP looks good for a buy here. We could see 4.00 soon after the 2.53 level has been crossed. Let's see if we can fill that gap. I'm not going to risk much here. If it loses momentum in the next few days it is not a good signal
